Intelligence Β· Clinical Pipeline

Phathom Pharmaceuticals Pipeline

All ClinicalTrials.gov programs at Phathom Pharmaceuticals β€” phase, modality, and trial IDs.

Programs
5

Quick answer

Phathom Pharmaceuticals has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Vonoprazan

    Phathom Pharmaceuticals

    Gastroesophageal Reflux

    phase 1 small molecule completed

    1 trial
  2. Vonoprazan

    Phathom Pharmaceuticals

    Gastroesophageal Reflux Disease

    phase 1 small molecule completed

    1 trial
  3. Vonoprazan

    Phathom Pharmaceuticals

    Healthy Participants

    phase 1 small molecule terminated

    2 trials
  4. Vonoprazan

    Phathom Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  5. Vonoprazan ODT-1 or ODT-2 without Water

    Phathom Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Phathom Pharmaceuticals have?

5 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs